CRISPR Therapeutics AG
ANTI-BCMA CAR-T-CELLS FOR PLASMA CELL DEPLETION
Last updated:
Abstract:
The present application relates to compositions and methods for controlled plasma cell depletion, such as for the treatment of various diseases and conditions associated with plasma cells.
Status:
Application
Type:
Utility
Filling date:
26 Apr 2019
Issue date:
29 Jul 2021